Company page

Samsung Biologics Co., Ltd.

Samsung Biologics Co., Ltd. is a leading biopharmaceutical company based in Korea, with a market capitalization of approximately 42.27 trillion KRW. The company specializes in contract manufacturing and offers a range of services for the development and production of biologic drugs. Samsung Biologics is recognized for its advanced facilities and commitment to quality in the biopharmaceutical industry.

profile207940AI content: aiUpdated May 29, 2026/company/samsung-biologics-co-ltd
Samsung Biologics Co., Ltd. logo
Ticker
207940
Market cap
$42.27B
Sector
Health Technology
Industry
Biotechnology